Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause

References

• Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: The challenges ahead. Lancet 2009;374:1196–208
   PubMed Web of Science ®Google Scholar
• de Villiers TJ, Pines A, Panay N, et al. on behalf of the International Menopause Society. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316–37
   PubMed Web of Science ®Google Scholar
• Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health 2013;5: 437–47
   PubMedGoogle Scholar
• Nappi RE, Lachowsky M. Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas 2009;63: 138–41
   PubMed Web of Science ®Google Scholar
• Palacios S. Managing urogenital atrophy. Maturitas 2009;63: 315–18
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kingsberg S, Maamari R, Simon J. The CLOSER (CLarifying Vaginal Atrophy’s Impact On SEx and Relationships) Survey: Implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med 2013;10:2232–41
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med 2013;10: 1790–9
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey. Climacteric 2012;15:36–44
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 2010;67:233–8
   PubMed Web of Science ®Google Scholar
• Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med 2009;6:2133–42
   PubMed Web of Science ®Google Scholar
• Bachmann GA, Leiblum SR, Grill J. Brief sexual inquiry in gynecologic practice. Obstet Gynecol 1989;73:425–7
   PubMed Web of Science ®Google Scholar
• Obermeyer CM, Reher D, Alcala LC, Price K. The menopause in Spain: results of the DAMES (Decisions At MEnopause) study. Maturitas 2005;52:190–8
   PubMed Web of Science ®Google Scholar
• Hunter MS, O’Dea I. Perception of future health risks in mid-aged women: estimates with and without behavioural changes and hormone replacement therapy. Maturitas 1999;33:37–43
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Krychman ML. Resistance and barriers to local estrogen therapy in women with atrophic vaginitis. J Sex Med 2013;10:1567–74
   PubMed Web of Science ®Google Scholar
• Nappi RE, Liekens G, Brandenburg U. Attitudes, perceptions and knowledge about the vagina: the International Vagina Dialogue Survey. Contraception 2006;73:493–500
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Panay N; International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
   PubMed Web of Science ®Google Scholar
• Rees M, Pérez-López FR, Ceasu I, et al. EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy. Maturitas 2012;73:171–4
   PubMed Web of Science ®Google Scholar
• NAMS. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20:888–902
   PubMed Web of Science ®Google Scholar
• Palacios S, Henderson VW, Siseles N, Tan D, Villaseca P. Age of menopause and impact of climacteric symptoms by geographical region. Climacteric 2010;13:419–28
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Juliá MD. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52:S46–52
   PubMed Web of Science ®Google Scholar
• Calleja-Agius J, Brincat MP. Urogenital atrophy. Climacteric 2009;12:279–85
   PubMed Web of Science ®Google Scholar
• Archer DF. Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 2010;17:194–203
   PubMed Web of Science ®Google Scholar
• Nappi RE, Polatti F. The use of estrogen therapy in women’s sexual functioning (CME). J Sex Med 2009;6:603–16
   PubMed Web of Science ®Google Scholar
• Bachmann GA, Leiblum SR. Sexuality in sexagenarian women. Maturitas 1991;13:43–50
   PubMed Web of Science ®Google Scholar
• Nappi RE, Lello S, Melis GB, Albani F, Polatti F, Genazzani AR. LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause. Climacteric 2009;12:533–40
   PubMed Web of Science ®Google Scholar
• Pandit L, Ouslander JG. Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 1997;314:228–31
   PubMed Web of Science ®Google Scholar
• Milsom I, Arvidsson L, Ekelund P, Molander U, Eriksson O. Factors influencing vaginal cytology, pH and bacterial flora in elderly women. Acta Obstet Gynecol Scand 1993;72: 286–91
   PubMed Web of Science ®Google Scholar
• Stika CS. Atrophic vaginitis. Dermatol Ther 2010;23:514–22
   PubMed Web of Science ®Google Scholar
• Mehta A, Bachmann G. Vulvovaginal complaints. Clin Obstet Gynecol 2008;51:549–55
   PubMed Web of Science ®Google Scholar
• Forsberg JG. A morphologist's approach to the vagina – age-related changes and estrogen sensitivity. Maturitas 1995;22: S7–15
   PubMed Web of Science ®Google Scholar
• Caillouette JC, Sharp CF Jr, Zimmerman GJ, Roy S. Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol 1997;176:1270–5
   PubMed Web of Science ®Google Scholar
• Simon JA. Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen. J Womens Health (Larchmt) 2011;20:1453–65
   PubMed Web of Science ®Google Scholar
• Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology 2003;62:45–51
   PubMed Web of Science ®Google Scholar
• World Health Organization. Sexual and Reproductive Health: Core Competencies in Primary Care. Geneva: WHO, 2011.
   Google Scholar
• Hinchliff S, Gott M. Seeking medical help for sexual concerns in mid- and later life: a review of the literature. J Sex Res 2011;48:106–17
   PubMed Web of Science ®Google Scholar
• Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281: 537–44
   PubMed Web of Science ®Google Scholar
• Herbenick D, Reece M, Schick V, Sanders S, Dodge B, Fortenberry JD. Sexual behavior in the United States: Results from a national probability sample of men and women ages 14 to 94. J Sex Med 2010;7:255–65
   PubMed Web of Science ®Google Scholar
• Schneidewind-Skibbe A, Hayes RD, Koochaki PE, Meyer J, Dennerstein L. The frequency of sexual intercourse reported by women: a review of community-based studies and factors limiting their conclusions. J Sex Med 2008;5:301–35
   PubMed Web of Science ®Google Scholar
• Nicolosi A, Laumann EO, Glasser DB, Moreira ED Jr, Paik A, Gingell C. Global Study of Sexual Attitudes and Behaviors Investigators’ Group. Sexual behavior and sexual dysfunctions after age 40: the Global Study of Sexual Attitudes and Behaviors. Urology 2004;64:991–7
   PubMed Web of Science ®Google Scholar
• Nappi RE, Nijland EA. Women’s perception of sexuality around the menopause: Outcomes of a European telephone survey. Eur J Obstet Gynecol Reprod Biol 2008;137:10–16
   PubMed Web of Science ®Google Scholar
• Barlow DH, Cardozo LD, Francis RM, et al. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997;104:87–91
   PubMedGoogle Scholar
• Ettinger B, Hait H, Reape KZ, Shu H. Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach. Menopause 2008;15:885–9
   PubMed Web of Science ®Google Scholar
• Lindau ST, Schumm LP, Laumann EO, Levinson W, O’Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357:762–74
   PubMed Web of Science ®Google Scholar
• Hayes R, Dennerstein L. The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies. J Sex Med 2005;2:317–30
   PubMed Web of Science ®Google Scholar
• Kao A, Binik YM, Amsel R, Funaro D, Leroux N, Khalifé S. Biopsychosocial predictors of postmenopausal dyspareunia: the role of steroid hormones, vulvovaginal atrophy, cognitive-emotional factors, and dyadic adjustment. J Sex Med 2012;9: 2066–76
   PubMed Web of Science ®Google Scholar
• Gass ML, Cochrane BB, Larson JC, et al. Patterns and predictors of sexual activity among women in the hormone therapy trials of the Women’s Health Initiative. Menopause 2011;18: 1160–71
   PubMed Web of Science ®Google Scholar
• Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative. Maturitas 2004;49:292–303
   PubMed Web of Science ®Google Scholar
• Goldstein I. Recognizing and treating urogenital atrophy in postmenopausal women. J Womens Health (Larchmt) 2010; 19:425–32
   PubMed Web of Science ®Google Scholar
• Constantine GD, Bruyniks N, Princic N, et al. Incidence of genitourinary conditions in women with a diagnosis of vulvar/vaginal atrophy. Curr Med Res Opin 2014;30:143–8
   PubMed Web of Science ®Google Scholar
• Gracia CR, Freeman EW, Sammel MD, Lin H, Mogul M. Hormones and sexuality during transition to menopause. Obstet Gynecol 2007;109:831–40
   PubMed Web of Science ®Google Scholar
• Avis NE, Brockwell S, Randolph JF, et al. Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women’s Health Across the Nation. Menopause 2009;16:442–52
   PubMed Web of Science ®Google Scholar
• Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol 2000; 152:463–73
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351–8
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause?Fertil Steril 2001;76:456–60
   PubMed Web of Science ®Google Scholar
• Nappi RE, Albani F, Santamaria V, et al. Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause. Maturitas 2010;67: 78–83
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Lehert P, Burger H. The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 2005; 84:174–80
   PubMed Web of Science ®Google Scholar
• Padmadas SS, Stones RW, Matthews Z. Dyspareunia and urinary sensory symptoms in India: population-based study. J Sex Med 2006;3:114–20
   PubMed Web of Science ®Google Scholar
• Ayers B, Forshaw M, Hunter MS. The impact of attitudes towards the menopause on women’s symptom experience: a systematic review. Maturitas 2010;65:28–36
   PubMed Web of Science ®Google Scholar
• Levine K, Williams R, Harmann K. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008; 15:661–6
   PubMed Web of Science ®Google Scholar
• Blümel JE, Chedraui P, Baron G, et al. Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index. Menopause 2009;16: 1139–48
   PubMed Web of Science ®Google Scholar
• Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med 2005;2(Suppl 3):154–65
   PubMed Web of Science ®Google Scholar
• Nappi RE. New attitudes to sexuality in the menopause: clinical evaluation and diagnosis. Climacteric 2007;10 (Suppl 2):105–8
   PubMed Web of Science ®Google Scholar
• Bachmann GA, Notelovitz M, Kelly SJ, et al. Long-term non-hormonal treatment of vaginal dryness. Clin Pract Sexuality 1992;8:3–8
   Google Scholar
• Greendale GA, Zibecchi L, Peterson L, Ouslander JG, Kahn B, Ganz PA. Development and validation of a physical examination scale to assess vaginal atrophy and inflammation. Climacteric 1999;2:197–204
   PubMedGoogle Scholar
• Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010;85:87–94
   PubMed Web of Science ®Google Scholar
• Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000;61:3090–6
   PubMed Web of Science ®Google Scholar
• Nilsson K, Risberg B, Heimer G. The vaginal epithelium in the post menopause – cytology, histology and pH as methods of assessment. Maturitas 1995;21:51–6
   PubMed Web of Science ®Google Scholar
• Doumouchtsis SK, Chrysanthopoulou EL. Urogenital consequences in ageing women. Best Pract Res Clin Obstet Gynaecol 2013; 27:699–714
   PubMed Web of Science ®Google Scholar
• Sadovsky R, Basson R, Krychman M, et al. Cancer and sexual problems. J Sex Med 2010;7:349–73
   PubMed Web of Science ®Google Scholar
• Stiles M, Redmer J, Paddock E, Schrager S. Gynecologic issues in geriatric women. J Womens Health (Larchmt) 2012; 21:4–9
   PubMed Web of Science ®Google Scholar
• Parmley TH, Woodruff JD. Complete vaginal occlusion in postmenopausal women. Obstet Gynecol 1975;46:235–8
   PubMed Web of Science ®Google Scholar
• Segal S, Harvie HS, Siegelman E, Arya LA. Severe atrophic vaginitis causing vaginal synechiae and hematocolpos at menopause. Menopause 2011;18:333–5
   PubMed Web of Science ®Google Scholar
• Bolton PJ, Selo-Ojeme DO. Endometrial adenocarcinoma: an unusual presentation with acute urinary retention secondary to haematocolpos. J Obstet Gynaecol 1999;19:553–4
   PubMedGoogle Scholar
• Utian WH, Maamari R. Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study. Climacteric 2013;17:29–36
   PubMed Web of Science ®Google Scholar
• Leiblum SR, Hayes RD, Wanser RA, Nelson JS. Vaginal dryness: a comparison of prevalence and interventions in 11 countries. J Sex Med 2009;6:2425–33
   PubMed Web of Science ®Google Scholar
• Simon JA, Kokot-Kierepa M, Goldstein J, Nappi RE. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey. Menopause 2013;20: 1043–8
   PubMed Web of Science ®Google Scholar
• Nappi RE, Davis SR. The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI. Climacteric 2012;15:267–74
   PubMed Web of Science ®Google Scholar
• Tan O, Bradshaw K, Carr BR. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review. Menopause 2012;19:109–17
   PubMed Web of Science ®Google Scholar
• Krychman ML. Vaginal estrogens for the treatment of dyspareunia. J Sex Med 2011;8:666–74
   PubMed Web of Science ®Google Scholar
• Basson R, Leiblum S, Brotto L, et al. Definitions of women’s sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol 2003;24:221–9
   PubMed Web of Science ®Google Scholar
• Fisher W, Rosen R, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: The female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005;2:675–84
   PubMed Web of Science ®Google Scholar
• Chedraui P, Perez-Lopez FR, San Miguel G, Avila C. Assessment of sexuality among middle-aged women using the Female Sexual Function Index. Climacteric 2009;12:213–21
   PubMed Web of Science ®Google Scholar
• Nappi RE, Mattsson LÅ, Lachowsky M, Maamari R, Giraldi A. The CLOSER survey: impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe. Maturitas 2013;75:373–9
   PubMed Web of Science ®Google Scholar
• Domoney C, Currie H, Panay N, Maamari R, Nappi RE. The CLOSER survey: impact of postmenopausal vaginal discomfort on women and male partners in the UK. Menopause Int 2013; 19:69–76
   PubMedGoogle Scholar
• Simon JA, Nappi RE, Kingsberg SA, Maamari R, Brown V. Clarifying Vaginal Atrophy’s Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Menopause 2013 Jun 3. Epub ahead of print
   Web of Science ®Google Scholar
• Nappi RE, Domoney C. Pharmacogenomics and sexuality: a vision. Climacteric 2013;16(Suppl 1):25–30
   PubMed Web of Science ®Google Scholar
• Al-Azzawi F, Bitzer J, Brandenburg U, et al. Therapeutic options for postmenopausal female sexual dysfunction. Climacteric 2010;13:103–20
   PubMed Web of Science ®Google Scholar
• Davis SR, Nijland EA. Pharmacological therapy for female sexual dysfunction: has progress been made?Drugs 2008;68: 259–64
   PubMed Web of Science ®Google Scholar
• Fooladi E, Davis SR. An update on the pharmacological management of female sexual dysfunction. Expert Opin Pharmacother 2012;13:2131–42
   PubMed Web of Science ®Google Scholar
• Portman DJ, Bachmann GA, Simon JA; Ospemifene Study Group. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause 2013;20:623–30
   PubMed Web of Science ®Google Scholar